ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Tennessee » Medical Oncology

Top Medical Oncology Prescribers in Tennessee

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KURT TAUER MD

Medical Oncology

3,066

$347K

407
343 are 65+

15%
patients receiving schedule two controlled substances

Avg: 16%

9%
patients receiving schedule three controlled substances

Avg: 19%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 18%

$113
Average prescription price

Avg: $349

LARRY SCHLABACH MD

Medical Oncology

3,045

$1.19M

371
280 are 65+

15%
patients receiving schedule two controlled substances

Avg: 16%

13%
patients receiving schedule three controlled substances

Avg: 19%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 18%

$390
Average prescription price

Avg: $349

LESTER PORTER MD

Medical Oncology

2,908

$347K

313
255 are 65+

25%
patients receiving schedule two controlled substances

Avg: 16%

24%
patients receiving schedule three controlled substances

Avg: 19%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 18%

$119
Average prescription price

Avg: $349

DIANNA SHIPLEY MD

Medical Oncology

2,216

$634K

304
241 are 65+

15%
patients receiving schedule two controlled substances

Avg: 16%

16%
patients receiving schedule three controlled substances

Avg: 19%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 18%

$286
Average prescription price

Avg: $349

JOHN MCCRAVEY MD

Medical Oncology

1,941

$885K

272
184 are 65+

10%
patients receiving schedule two controlled substances

Avg: 16%

19%
patients receiving schedule three controlled substances

Avg: 19%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 18%

$456
Average prescription price

Avg: $349

NANCY PEACOCK MD

Medical Oncology

1,501

$294K

180
149 are 65+

11%
patients receiving schedule two controlled substances

Avg: 16%

9%
patients receiving schedule three controlled substances

Avg: 19%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 18%

$196
Average prescription price

Avg: $349

MICHEL KUZUR MD

Medical Oncology

1,386

$342K

143
128 are 65+

14%
patients receiving schedule two controlled substances

Avg: 16%

22%
patients receiving schedule three controlled substances

Avg: 19%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

10%
prescriptions for brand name drugs

Avg: 18%

$246
Average prescription price

Avg: $349

CHET JAMESON MD

Medical Oncology

1,298

$724K

214
163 are 65+

11%
patients receiving schedule two controlled substances

Avg: 16%

17%
patients receiving schedule three controlled substances

Avg: 19%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 18%

$558
Average prescription price

Avg: $349

JAMES PEYTON M.D.

Medical Oncology

1,272

$284K

169
138 are 65+

18%
patients receiving schedule two controlled substances

Avg: 16%

8%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 18%

$223
Average prescription price

Avg: $349

PATRICK MURPHY M.D.

Medical Oncology

1,263

$404K

159
135 are 65+

18%
patients receiving schedule two controlled substances

Avg: 16%

21%
patients receiving schedule three controlled substances

Avg: 19%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 18%

$320
Average prescription price

Avg: $349

DANA THOMPSON M.D.

Medical Oncology

1,147

$808K

169
137 are 65+

28%
patients receiving schedule two controlled substances

Avg: 16%

18%
patients receiving schedule three controlled substances

Avg: 19%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 18%

$705
Average prescription price

Avg: $349

MARK MAINWARING MD

Medical Oncology

1,137

$549K

178
127 are 65+

16%
patients receiving schedule two controlled substances

Avg: 16%

8%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

12%
prescriptions for brand name drugs

Avg: 18%

$483
Average prescription price

Avg: $349

MAINUDDIN AHMED M.D.

Medical Oncology

1,127

$658K

189
137 are 65+

13%
patients receiving schedule two controlled substances

Avg: 16%

11%
patients receiving schedule three controlled substances

Avg: 19%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 18%

$584
Average prescription price

Avg: $349

VICTOR GIAN M.D.

Medical Oncology

1,121

$516K

172
131 are 65+

15%
patients receiving schedule two controlled substances

Avg: 16%

14%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 18%

$460
Average prescription price

Avg: $349

JASON CHANDLER MD

Medical Oncology

1,106

$248K

144
102 are 65+

20%
patients receiving schedule two controlled substances

Avg: 16%

23%
patients receiving schedule three controlled substances

Avg: 19%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 18%

$224
Average prescription price

Avg: $349

DWIGHT KAUFMAN MD

Medical Oncology

1,092

$473K

204
166 are 65+

11%
patients receiving schedule two controlled substances

Avg: 16%

14%
patients receiving schedule three controlled substances

Avg: 19%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

12%
prescriptions for brand name drugs

Avg: 18%

$433
Average prescription price

Avg: $349

JOHN BARTON M.D.

Medical Oncology

1,040

$285K

143
121 are 65+

13%
patients receiving schedule two controlled substances

Avg: 16%

14%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 18%

$274
Average prescription price

Avg: $349

DAVID SPIGEL M.D.

Medical Oncology

977

$518K

119
100 are 65+

23%
patients receiving schedule two controlled substances

Avg: 16%

22%
patients receiving schedule three controlled substances

Avg: 19%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 18%

$530
Average prescription price

Avg: $349

EUGENE REESE MD

Medical Oncology

954

$332K

107
87 are 65+

0%
patients receiving schedule two controlled substances

Avg: 16%

0%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 18%

$348
Average prescription price

Avg: $349

MALCOLM MATHEWS MD

Medical Oncology

942

$817K

162
124 are 65+

14%
patients receiving schedule two controlled substances

Avg: 16%

12%
patients receiving schedule three controlled substances

Avg: 19%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 18%

$867
Average prescription price

Avg: $349

STUART SPIGEL MD

Medical Oncology

904

$423K

104
85 are 65+

17%
patients receiving schedule two controlled substances

Avg: 16%

26%
patients receiving schedule three controlled substances

Avg: 19%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 18%

$468
Average prescription price

Avg: $349

ROHIT PATEL MD

Medical Oncology

884

$133K

158
126 are 65+

13%
patients receiving schedule two controlled substances

Avg: 16%

16%
patients receiving schedule three controlled substances

Avg: 19%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

13%
prescriptions for brand name drugs

Avg: 18%

$150
Average prescription price

Avg: $349

MARK MESSENGER MD

Medical Oncology

855

$424K

154
124 are 65+

20%
patients receiving schedule two controlled substances

Avg: 16%

16%
patients receiving schedule three controlled substances

Avg: 19%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

10%
prescriptions for brand name drugs

Avg: 18%

$496
Average prescription price

Avg: $349

RUTH LAMAR M.D.

Medical Oncology

832

$244K

111
102 are 65+

13%
patients receiving schedule two controlled substances

Avg: 16%

0%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 18%

$294
Average prescription price

Avg: $349

JAMAL MAATOUK MD

Medical Oncology

826

$267K

150
104 are 65+

16%
patients receiving schedule two controlled substances

Avg: 16%

13%
patients receiving schedule three controlled substances

Avg: 19%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 18%

$323
Average prescription price

Avg: $349

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank